Shareholders of Infant Bacterial Therapeutics AB (publ) are summoned to the Annual General Meeting on Tuesday, May 4, 2021. In light of the coronavirus...
Infant Bacterial Therapeutics (IBT) announces that the company has reached an important milestone after recruiting 300 premature infants to the ongoing...
2021-02-09 20:00
Infant Bacterial Therapeutics today announces that new patent protection is granted in Japan
Infant Bacterial Therapeutics AB today announces that the Japan Patent Office has issued a decision to grant a patent entitled: A method of activating...
2021-02-05 08:00
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2020
Message from the CEO IBT is currently developing its lead drug candidate IBP-9414 to prevent necrotizing enterocolitis (NEC), and to improve so-called...
2020-11-05 08:00
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2020
Message from the CEO IBT is currently developing its lead drug candidate IBP-9414 to prevent necrotizing enterocolitis (NEC), and to improve so-called...
2020-08-14 08:00
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2020
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2020 Message from the CEO IBT is currently developing...
2020-06-16 17:00
Annual General Meeting of Infant Bacterial Therapeutics
At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on June 16, 2020, among other things, the following was resolved: About Infant...
Shareholders of Infant Bacterial Therapeutics AB (publ) are summoned to the Annual General Meeting on Tuesday, June 16, 2020. In light of the coronavirus...
2020-05-11 16:00
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1-March 31, 2020
Message from the CEO IBT is currently developing its lead drug candidate IBP-9414 to prevent necrotizing enterocolitis (NEC), and to improve so called...
2020-04-03 14:05
Infant Bacterial Therapeutics publishes Annual Report for 2019
Infant Bacterial Therapeutics AB (publ) has today published the Annual Report for 2019. The report is available on IBT’s website ibtherapeutics.com...